Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK and MEXICO CITY, Feb. 6, 2015 (GLOBE NEWSWIRE) -- Bolsa Mexicana de Valores, S.A.B. de C.V. (Mexican Stock Exchange) has announced it has reached a license agreement with Nasdaq (Nasdaq:NDAQ)...
-
ORLANDO, Fla., Feb. 6, 2015 (GLOBE NEWSWIRE) -- Combining over 40 years of game production experience, fellow independent developers n-Space and Digital Extremes announced today a partnership that...
-
SPOKANE, Wash., Feb. 2, 2015 (GLOBE NEWSWIRE) -- RLHC (Red Lion Hotels Corporation) (NYSE:RLH) announced the company has sold the Red Lion Hotel Wenatchee in Washington. The new owners, who also own a...
-
LAS VEGAS, Jan. 30, 2015 (GLOBE NEWSWIRE) -- iCONECT Development, LLC, a technology leader that develops intuitive, web-based eDiscovery software and Ricoh Americas Corporation, a global technology...
-
Denver, Colorado, Jan. 28, 2015 (GLOBE NEWSWIRE) -- FutureWorld Corp. (OTC: FWDG), a leading provider of advanced technologies and solutions to the global cannabis industry, announced that CB...
-
TEANECK, N.J., Jan. 26, 2015 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (Nasdaq:PAHC) today announced it has entered into a long-term global license arrangement with Merial SAS (Lyon,...
-
TEANECK, N.J., Jan. 22, 2015 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation ("Phibro") (Nasdaq:PAHC) today announced it has acquired exclusive North American distribution rights for vaccines...
-
ANAHEIM, Calif., Jan. 22, 2015 (GLOBE NEWSWIRE) -- NAMM (Hall A, Booth #6400) -- Avid® (Nasdaq: AVID) today announced Pro Tools® 12, the next generation of the industry-standard digital...
-
-- Agreement Provides Curis with Option to Exclusively License Aurigene's Antagonists for Immuno-Oncology, Including an Antagonist of PD-L1 and Selected Precision Oncology Targets, Including an...
-
SAN FRANCISCO and GENEVA, Jan. 15, 2015 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of novel diagnostic tests in neurology...